selected scholarly activity
-
conferences
- Medical Cannabis Use in Patients Attending Rheumatology Clinics in Ontario. Journal of Rheumatology. 1118-1118. 2021
- AB0857 CERTOLIZUMAB PEGOL RELOADING SUCCESSFULLY CONTROLS INFLAMMATORY ARTHRITIS FLARES DURING PREGNANCY – A CASE REPORT. Annals of the Rheumatic Diseases. 1452.1-1452. 2021
- OP0143 IMPACT OF ADALIMUMAB VERSUS NON-BIOLOGIC THERAPY ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ANKYLOSING SPONDYLITIS OVER 24 MONTHS – RESULTS OF THE COMPLETE-AS CANADIAN OBSERVATIONAL STUDY. Annals of the Rheumatic Diseases. 84.2-85. 2021
- Prevalence and Predictors of Depression among Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Canadian Real World Observational Cohort: Results from the COMPLETE Studies. Journal of Rheumatology. 1041-1041. 2020
- Prevalence of Work Disability and Predictors of Work Productivity among Employable Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Canadian Real World Observational Cohort: Interim Results from the COMPLETE Studies. Journal of Rheumatology. 1042-1042. 2020
- Anakinra Exposure in a Pregnant Patient with Juvenile Idiopathic Arthritis: A Case Report. Journal of Rheumatology. 830-830. 2019
- No Evidence for an Increased Risk of Infection in Newborns and Postpartum Mothers after Exposure to Biologics in the Third Trimester: A Single Center Observational Cohort Study. Journal of Rheumatology. 841-841. 2019
- Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care. Journal of Rheumatology. 850-851. 2019
- Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care. Journal of Rheumatology. 818-818. 2019
- SAT0318 PREVALENCE AND PREDICTORS OF DEPRESSION AMONG PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN A CANADIAN REAL WORLD OBSERVATIONAL COHORT: RESULTS FROM THE COMPLETE STUDIES. Annals of the Rheumatic Diseases. 1237-1238. 2019
- THU0371 PREVALENCE OF WORK DISABILITY AND PREDICTORS OF WORK PRODUCTIVITY AMONG EMPLOYABLE PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS IN A CANADIAN REAL WORLD OBSERVATIONAL COHORT: INTERIM RESULTS FROM THE COMPLETE STUDIES. Annals of the Rheumatic Diseases. 469-470. 2019
- Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care. Arthritis & Rheumatology. 2018
- Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care. Arthritis & Rheumatology. 2018
- CANADIAN OBSERVATIONAL STUDY ASSESSING THE EFFECTIVENESS OF ADALIMUMAB VS. NON-BIOLOGIC DMARDS IN ANKYLOSING SPONDYLITIS (COMPLETE-AS): 12-MONTH DATA. Clinical and Experimental Rheumatology. 722-722. 2018
- CANADIAN OBSERVATIONAL STUDY ASSESSING THE EFFECTIVENESS OF ADALIMUMAB VS. NON-BIOLOGIC DMARDS IN PSORIATIC ARTHRITIS (COMPLETE-PsA): 12-MONTH DATA. Clinical and Experimental Rheumatology. 723-723. 2018
- AB0935 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs non-biologic dmards in psoriatic arthritis (COMPLETE-PSA): 12-month effectiveness data. Annals of the Rheumatic Diseases. 1592-1592. 2018
- SAT0290 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs. non-biologic dmards in ankylosing spondylitis (COMPLETE-AS): 12-month effectiveness data. Annals of the Rheumatic Diseases. 1008-1009. 2018
- CANADIAN HUMIRA POST-MARKETING OBSERVATIONAL EPIDEMIOLOGICAL STUDY ASSESSING THE EFFECTIVENESS OF ADALIMUMAB VS NON-BIOLOGIC DMARDS IN PSORIATIC ARTHRITIS (COMPLETE-PSA): 12-MONTH EFFECTIVENESS DATA. Acta Dermato-Venereologica. 15-15. 2018
- Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-world Setting. Journal of Rheumatology. 910-910. 2017
- Impact of HLA-B27 on Patient Profile and Treatment Response in As Patients Treated with Anti-TNF in Canadian Real-World. Arthritis & Rheumatology. 2016
- Empirical Treatment of Dermatomyositis with Intravenous Immunoglobulin in Pregnant Patient. Journal of Rheumatology. 1499-1500. 2014
- BMD Shows Osteoporosis in only 25% of Males with Known Fragility Fracture, Resulting in Significant Under-Treatment and Fracture Protection. Journal of Rheumatology. 1340-1340. 2010
-
journal articles
- Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results. Journal of Rheumatology. 46:874-886. 2019
- Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE). Diabetes Care. 39:709-716. 2016
- Endocrine and Miscellaneous Arthropathies 2015
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia. New England Journal of Medicine. 367:309-318. 2012
- The Relationship of Body Mass Index to Outcomes after Percutaneous Coronary Intervention. Journal of Interventional Cardiology. 19:388-395. 2006